**Haemophilia Wales Trustees Annual Report** : November 1[st] 2019-31[st] October 2020 

We continue to provide information and support to Haemophilia and transfusion patients and families across Wales. 

Haemophilia Wales attended the Infected Blood Inquiry Hearings in London and participated in the Inquiry Engagement meetings in North and South Wales. 

The Cross Party Group at the Welsh Assembly met 3 times and patients and families were given updates on the progress of the Inquiry and service provision in Haemophilia care across Wales. 

Much of our work has focused on strengthening the North Wales Haemophilia service and patients and staff meetings continue to ensure that these improvements are implemented. 

Caroline Coffey Clinical Psychologist and Julie Armytage were appointed to provide Psychological support at the Wales Infected Blood Support Scheme. As a result of continued engagement with Haemophilia Centres across Wales 2 Haemophilia Consultants and 2 Haemophilia nurses were appointed. 

Haemophilia Wales attended a meeting at the Cabinet Office to discuss levelling Infected Blood Support payments across the UK as requested by Sir Brian Langstaff Chair of the Infected Blood Inquiry. 




> **Charity No 1158941 CC16a Haemophillia Wales Receipts and payments accounts For the period from** 01/11/2019 **For the period to** 31/10/2020 

## **Section A Receipts and payments** 

|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**|<br>**Restricted**<br>**funds**<br> <br>**to the**<br>**nearest £**|<br>**Endowme**<br>**nt funds**<br>**to the**<br>**nearest £**|**Total**<br>**funds**<br>**to the**<br>**nearest £**|**Last year**<br>**to the nearest**<br>**£**|
|---|---|---|---|---|---|
|Voluntary Income|**-**|**-**|**-**|**-**|**-**|
|Grants||**-**|**-**|**-**||
|Donations|**898**|**-**|**-**|**898**||
|Interest|**29**|**-**|**-**|**29**||
|||**-**|**-**|**-**|**-**|
||**-**|**-**|**-**|**-**|**-**|
||**-**|**-**|**-**|**-**|**-**|
||**-**|**-**|**-**|**-**|**-**|
|**_Sub_**<br>**_total_**_(Gross_<br>_income for AR)_|**927**|||**927**|**3,981**|
|||||||
|**investment**<br>**sales, (see**||||||
||**-**|**-**|**-**|**-**||
||**-**|**-**|**-**|**-**|**-**|
|**_Sub total_**|**-**|**-**|**-**|**-**|**-**|
|**_Total receipts_**<br>**A3 Payments**||||||
||**927**|**-**|**-**|**927**|**3,981**|
|||||||
|||**-**|**-**||**-**|
|Activity days|**93**|**-**|**-**|**93**||
|Hardship funds|**470**|**-**|**-**|**470**||
|Administration|**2,114**|**-**|**-**|**2,114**||
|||**-**|**-**|||
|||**-**|**-**|**-**|**-**|
|||**-**|**-**|**-**|**-**|
|||**-**|**-**|**-**|**-**|
||**-**|**-**|**-**||**-**|
|**_Sub total_ **|**2,677**|**-**|**-**|**2,677**|**5,777**|





|**A4 Asset and**<br>**investment**<br>**purchases, (see**<br>**table)**|||||**-**<br>**5,777**<br>**1,796**<br>**-**|**-**<br>**5,777**<br>**1,796**<br>**-**|
|---|---|---|---|---|---|---|
||**-**|**-**|**-**|**-**|||
||**-**|**-**|**-**|**-**|||
|**_Sub total_ **<br>**_Total payments_**<br>**_Net of_**<br>**_receipts/(pay_**<br>**_ments)_**<br>**A5 Transfers**<br>**between funds**<br>**A6 Cash funds**<br>**last year end**<br>**_Cash funds_**<br>**_this year end_**|**2,677**|**-**|**-**|**2,677**|**-**||
||||||||
||**2,677**|**-**|**-**|**2,677**|**5,777**||
||||||||
||**1,750**|<br>**-**|**-**|**1,750**|**1,796**||
|||**-**|**-**||**-**||
||**6,920**|<br>**-**|**-**|**6,920**|**7,923**||
||**5,170**|<br>**-**|**-**|**5,170**|**6,127**||